Appareil pulmonaire
HERTHENA-Lung01 U31402-A-U201
HERTHENA-Lung01: A Phase 2 Randomized Open-Label;Study of Patritumab Deruxtecan (U3-1402) in Subjects with;Previously Treated Metastatic or Locally Advanced EGFRmutated;Non-Small Cell Lung Cancer (NSCLC)
Paris
NICOLAS GIRARD